Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Elena Guerini Rocco"'
Autor:
Lisa Rinaldi, Elena Guerini Rocco, Gianluca Spitaleri, Sara Raimondi, Ilaria Attili, Alberto Ranghiero, Giulio Cammarata, Marta Minotti, Giuliana Lo Presti, Francesca De Piano, Federica Bellerba, Gianluigi Funicelli, Stefania Volpe, Serena Mora, Cristiana Fodor, Cristiano Rampinelli, Massimo Barberis, Filippo De Marinis, Barbara Alicja Jereczek-Fossa, Roberto Orecchia, Stefania Rizzo, Francesca Botta
Publikováno v:
Cancers, Vol 15, Iss 18, p 4553 (2023)
Non-invasive methods to assess mutational status, as well as novel prognostic biomarkers, are warranted to foster therapy personalization of patients with advanced non-small cell lung cancer (NSCLC). This study investigated the association of contras
Externí odkaz:
https://doaj.org/article/5346dd5ede3a4c708474bf9f1f815e73
Autor:
Edoardo Crimini, Matteo Repetto, Paolo Tarantino, Liliana Ascione, Gabriele Antonarelli, Elena Guerini Rocco, Massimo Barberis, Luca Mazzarella, Giuseppe Curigliano
Publikováno v:
Cancers, Vol 14, Iss 13, p 3193 (2022)
Considering the rapid improvement of cancer drugs’ efficacy and the discovery of new molecular targets, the formulation of therapeutical indications based on the multidisciplinary approach of MTB is becoming increasingly important for attributing t
Externí odkaz:
https://doaj.org/article/6ed18f9483554e43ae8dc6e21648a6c2
Autor:
Caterina Fumagalli, Ilaria Betella, Alessandra Rappa, Maria di Giminiani, Michela Gaiano, Luigi Antonio De Vitis, Benedetta Zambetti, Davide Vacirca, Francesco Multinu, Konstantinos Venetis, Nicoletta Colombo, Massimo Barberis, Elena Guerini Rocco
Publikováno v:
Cancers, Vol 14, Iss 7, p 1638 (2022)
The establishment of PARP inhibitors in the treatment of epithelial ovarian carcinoma (EOC) has prompt BRCA assessment at the time of diagnosis. We described our five years of experience of tumor BRCA testing, as part of a multidisciplinary workflow
Externí odkaz:
https://doaj.org/article/98d699bc2b164318819c8fdd9d84d208
Autor:
Ramona Erber, Arndt Hartmann, Peter Andreas Fasching, Matthias Ruebner, Robert Stöhr, Matthias Wilhelm Beckmann, Miriam Zentgraf, Verena Popp, Jodi Weidler, Iris Simon, Steffi Becker, Hanna Huebner, Josephine Fischer, Elena Guerini Rocco, Giuseppe Viale, Anne Cayre, Frederique Penault-Llorca, Tamara Caniego Casas, Belén Pérez-Miés, José Palacios, Paul Jank, Carsten Denkert, Lina Khoury, Thomas Mairinger, Fulvia Ferrazzi
Publikováno v:
Cancers, Vol 13, Iss 18, p 4718 (2021)
Estrogen receptor (ER), progesterone receptor (PgR), Ki-67, and HER2 immunohistochemistry (IHC) together with HER2 in situ hybridization (ISH) are utilized to classify invasive breast cancer (IBC) into predictive molecular subtypes. As IHC evaluation
Externí odkaz:
https://doaj.org/article/7f0837bf2b20454889f29261fb4d8402
Autor:
Fabio Pagni, Umberto Malapelle, Claudio Doglioni, Gabriella Fontanini, Filippo Fraggetta, Paolo Graziano, Antonio Marchetti, Elena Guerini Rocco, Pasquale Pisapia, Elena V. Vigliar, Fiamma Buttitta, Marta Jaconi, Nicola Fusco, Massimo Barberis, Giancarlo Troncone
Publikováno v:
Cancers, Vol 12, Iss 7, p 1800 (2020)
A meeting among expert pathologists was held in 2019 in Rome to verify the results of the previous harmonization efforts on the PD-L1 immunohistochemical testing by scoring a representative series of non-small cell lung cancer (NSCLC) digital slides.
Externí odkaz:
https://doaj.org/article/00ef3979bfdb47e3adb56c528d96eb15
Autor:
Mariarosaria Calvello, Manuela Bottoni, Maria Sofia Fernandes, Gabriella Pravettoni, Cristina Trovato, Giulia Massari, Nicola Fusco, Francesca De Lorenzi, Giovanni Corso, Joao Sanches, Bernardo Bonanni, Raquel Seruca, Uberto Fumagalli Romario, Susana Seixas, Elena Guerini-Rocco, Carlo La Vecchia, Anna Rotili, Giacomo Montagna, Serena Petrocchi, Franco Roviello, Viviana Galimberti, Joana Figueiredo, Francesca Magnoni
Publikováno v:
Cancers
Cancers, Vol 12, Iss 1598, p 1598 (2020)
Cancers, Vol 12, Iss 1598, p 1598 (2020)
E-cadherin (CDH1 gene) germline mutations are associated with the development of diffuse gastric cancer in the context of the so-called hereditary diffuse gastric syndrome, and with an inherited predisposition of lobular breast carcinoma. In 2019, th
Autor:
Giuseppe Viale, Mariarosaria Calvello, Loris Bernard, Nicoletta Colombo, Fedro A. Peccatori, Ilaria Betella, Bernardo Bonanni, Elena Guerini-Rocco, Massimo Barberis, Federica Tomao, Alessandra Rappa, Caterina Fumagalli
Publikováno v:
Cancers, Vol 11, Iss 11, p 1641 (2019)
Cancers
Volume 11
Issue 11
Cancers
Volume 11
Issue 11
The PARP inhibitor olaparib has been approved in the maintenance setting of platinum-sensitive epithelial ovarian cancer patients with germline or somatic BRCA1/2 mutation. Therefore, the availability of a tumor BRCA test has become a clinical need.
Publikováno v:
Cancers
Cancers, Vol 13, Iss 609, p 609 (2021)
Cancers, Vol 13, Iss 609, p 609 (2021)
Personalized cancer therapy matches the plan of treatment with specific molecular alterations [...]
Autor:
Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli, Giulia d’Amati, Francesca Maria Porta, Elena Guerini-Rocco, Carmen Criscitiello, Giuseppe Curigliano, Nicola Fusco
Publikováno v:
Cancers, Vol 16, Iss 11, p 1981 (2024)
Effective risk assessment in early breast cancer is essential for informed clinical decision-making, yet consensus on defining risk categories remains challenging. This paper explores evolving approaches in risk stratification, encompassing histopath
Externí odkaz:
https://doaj.org/article/7a6001d5bd6440e38dfc0e2e13148902
Publikováno v:
Cancers, Vol 15, Iss 22, p 5430 (2023)
Early breast cancer (BC) is the definition applied to breast-confined tumors with or without limited involvement of locoregional lymph nodes. While risk stratification is essential for guiding clinical decisions, it can be a complex endeavor in these
Externí odkaz:
https://doaj.org/article/194d2ab3fbf24d4bb51e5f014f014596